Lantern

Global A.I. Medical Diagnostics Market Poised To Reach $3.7 Billion By 2028

Retrieved on: 
Wednesday, March 20, 2024
Tendinopathy, Artificiality, Health, Patient, Conditional sentence, History, Artificial intelligence, Lantern, Mantle cell lymphoma, OTCQX, Microsoft HoloLens, Context, Corporation, NEO, Microsoft, Automation, MCL, DHL, Splenic infarction, Diabetes, Risk, PALM, Radiology, Software, Treatment, UiPath, OTCQB, Strategic alliance, Prevalence, Disease, Microsoft Mesh, Hospital, Research, News, WELL, Student, TSX, MPH, Nursing, Machine learning, Diagnosis, TED (conference), OSCE, Growth, Cancer, Trust, Sarcoma, NHL, Appendicitis, Ecosystem, Probability, AIDX, Medical device

A report from MarketsAndMarkets opined that the global AI in medical diagnostics market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028.

Key Points: 
  • A report from MarketsAndMarkets opined that the global AI in medical diagnostics market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028.
  • MarketsAndMarkets continued: “Based on component, the AI in medical diagnostics market is bifurcated into software, services, and hardware.
  • The software segment accounted for the largest share of the global AI in medical diagnostics Market in 2022.
  • The hospitals segment accounted for the largest share of the global AI in medical diagnostics Market in 2022.

The "Spring Festival Festival Festival" in Chengdu has come to an end

Retrieved on: 
Thursday, February 29, 2024
Education, Culture, City, China Global Television Network, Chairperson, Wave, Lantern Festival, Tencent, Spring Festival, VR, Animation, Beauty, Social media, The Spring Festival, Twin Towers, Tourism, Nanyang Technological University, All Nations, Taste, International University Sports Federation, WeChat, Multimedia, Ice, Cultural attaché, Witness, Mass migration, Diplomatic mission, Sport, Snow, Hot Cities, Lantern, Internet, New Spring, AI, Friends, Year of the Dragon, Consul, Lunar New Year, CGTN, Hanfu, Painting, Athlete, Chinese New Year

CHENGDU, China, Feb. 28, 2024 /PRNewswire/ -- On the night of February 24th, the lanterns in Chengdu were bright and dazzling, with countless Spring Festival activities blooming in various places in Chengdu. The Year of the Dragon came to a close amidst the lively atmosphere of fireworks and excitement, marking a vibrant start to the Chinese people's 2024. In the midst of this festive tourism atmosphere, how "hot and spicy" is Chengdu?

Key Points: 
  • Statistics show that during the Spring Festival period, GoChengdu ranked first on both Facebook and X platforms among national central city accounts.
  • On Lantern Festival day, GoChengdu released the creative short film "Strolling in the December Market Painting," capturing the festive atmosphere of Lantern Festival in Chengdu.
  • The short film creatively uses VR gaming settings to recreate the prosperous scene of the December market in Song Dynasty Chengdu.
  • On the Xiaohongshu platform, there are over 1.64 million notes recording the "Chengdu Spring Festival Travel Guide," inspiring global netizens to explore Chengdu through the internet.

2024 'Nihao! China' Lantern Festival: 24-hour live broadcast

Retrieved on: 
Friday, February 23, 2024
Weibo, Love, Ni Hao, Lantern, The Spring Festival, Multimedia, Snow World, Culture, Chinese, Brilliant, City, Lantern Festival, Spring Festival, Snow

China" Lantern Festival 24-Hour Live Global Broadcast event.

Key Points: 
  • China" Lantern Festival 24-Hour Live Global Broadcast event.
  • This live broadcast will cover six cities in four countries: China, France, Hungary and Italy, presenting an unprecedented visual and cultural feast.
  • Let us look forward to this cross-border Lantern Festival global live broadcast event, experiencing the festive atmosphere and unique charm of the Lantern Festival from around the world.
  • China" Lantern Festival 24-Hour Live Global Broadcast event is hosted by China Daily website and is part of the 2024 global celebration of Happy Chinese New Year Program.

Starlight Therapeutics, a Subsidiary of Lantern Pharma Focused on CNS & Brain Cancers, Announces Dr. Marc Chamberlain as Chief Medical Officer

Retrieved on: 
Wednesday, January 17, 2024
Oncology, Health, Technology, Artificial Intelligence, Pharmaceutical, Biotechnology, University, Neoplasm, Lantern, Patient, Therapy, Research, Neurology, Glioblastoma, UC, Multimedia, Neuro, Brain, DIPG, Cancer, NCI, Starlight, ATRT, USC, Central nervous system, Seagen, Physician, CNS, Pharmaceutical industry

Starlight Therapeutics— a Lantern Pharma (Nasdaq: LTRN) subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective therapeutic options— today announced that Marc Chamberlain, M.D.

Key Points: 
  • Starlight Therapeutics— a Lantern Pharma (Nasdaq: LTRN) subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective therapeutic options— today announced that Marc Chamberlain, M.D.
  • has joined Starlight as its Chief Medical Officer.
  • In his role, Dr. Chamberlain will apply his significant medical, clinical, and pharmaceutical development expertise to advance Starlight’s AI-enabled and accelerated drug development portfolio.
  • “Starlight, in collaboration with Lantern Pharma, is poised to advance its novel central nervous system (CNS) penetrant wholly synthetic acylfulvene, LP-184 (referred to as “STAR-001” for CNS indications), to target tumors in the brain.

OrthAlign Inc Celebrates a Record Year with Over $50MM in Global Revenue in 2023

Retrieved on: 
Tuesday, January 9, 2024
Lantern, ASC, Patient, Abdominal ultrasonography, Multimedia, Hip, Robotics, Elective surgery, Surgeon, Growth

ALISO VIEJO, Calif., Jan. 9, 2024 /PRNewswire/ -- OrthAlign Inc, a leading innovator in surgical technology, announces over $50MM in Global Revenue in its 2023 fiscal year, achieving record milestones in revenue, patient reach, and market expansion.

Key Points: 
  • ALISO VIEJO, Calif., Jan. 9, 2024 /PRNewswire/ -- OrthAlign Inc, a leading innovator in surgical technology, announces over $50MM in Global Revenue in its 2023 fiscal year, achieving record milestones in revenue, patient reach, and market expansion.
  • OrthAlign technology has been used in over 325,000 procedures worldwide, with 56,000 in 2023.
  • This revenue and procedural growth highlight the surge in demand from healthcare providers seeking surgical solutions that are accurate, efficient, and cost-effective.
  • OrthAlign expanded its footprint in the Ambulatory Surgical Centers (ASC) by adding 25% more facilities and achieved over 37% revenue growth in the segment.

Sugarfina Releases Exclusive Year of the Dragon Collection

Retrieved on: 
Wednesday, January 3, 2024
Star, Candy, Family, Nelumbo, Culture, Collection, Friends, System, Lunar New Year, Gold, Netflix, Personality, Animal, LOS, Lantern

LOS ANGELES, Jan. 3, 2024 /PRNewswire/ -- Sugarfina is starting 2024 off on a sweet note! Known as one of the luckiest animals in the Zodiac, the luxury candy boutique is honoring the Year of the Dragon with a special-edition collection filled with celebratory gifts meant for sharing good luck in the year ahead. 

Key Points: 
  • Designed and curated in collaboration with Netflix's Bling Empire star and lifestyle influencer Cherie Chan, the exclusive release features gold coin-inspired Sugarfina Candy Cubes®, keepsake Candy Bento Boxes®, a Zodiac Candy Tasting Collection, and a luxury Candy Trunk.
  • Lucky recipients of the Year of the Dragon Candy Trunk will also receive a limited-edition Dragon Charm to hang on purses, suitcases, or backpacks.
  • Good health, prosperity, and great fortune were kept in mind while Cherie and the Sugarfina Team created these special candy boxes and flavors!
  • "This year's Lunar New Year Collection is truly spectacular," says Scott LaPorta, CEO, and Co-Investor of Sugarfina.

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in High-Grade B-cell Lymphomas (HGBL)

Retrieved on: 
Thursday, November 30, 2023
Oncology, FDA, Health, Technology, Artificial Intelligence, Pharmaceutical, BCL2, DNA, Food, Rituximab, MYC, MCL, ODD, IND, A.I, Patient, Artificial intelligence, Marketing, Machine learning, SOHO, Prognosis, Diagnosis, Death, Lymphoma, Survival, NHL, Pharmaceutical industry, Lantern

HGBL represents a rare and aggressive form of B-cell non-Hodgkin's lymphoma (NHL) with no established standard of care treatment approach.

Key Points: 
  • HGBL represents a rare and aggressive form of B-cell non-Hodgkin's lymphoma (NHL) with no established standard of care treatment approach.
  • For those with relapsed or refractory (R/R) disease, the survival prognosis is 8.6 to 16 months (Laude et al., 2021) .
  • "Receiving Orphan Drug Designation is an important milestone for our latest drug candidate, LP-284, and further validates our data-driven approach to oncology drug discovery and development,” stated Panna Sharma, President & CEO of Lantern Pharma.
  • “This marks the second Orphan Drug Designation (ODD) granted by the FDA for LP-284.

Atmosphere Dedicates $1 Million in Advertising Inventory to Honor Small Business Champions

Retrieved on: 
Wednesday, November 15, 2023
Social Media, Retail, Online, Technology, Marketing, Advertising, Small Business, Communications, Professional Services, TV and Radio, Restaurant, Bar, Other Technology, Media, Entertainment, Digital Marketing, Atmosphere, Small business, Heart, System, Social media, Dream, Lantern, Ship Bottom, New Jersey, CTV, FAST, Growth, Television

Atmosphere , the premier CTV FAST platform tailored exclusively for businesses, is unveiling a dedicated campaign that grants $1 million in advertising inventory to local establishments within Atmosphere’s vast network of small business venues.

Key Points: 
  • Atmosphere , the premier CTV FAST platform tailored exclusively for businesses, is unveiling a dedicated campaign that grants $1 million in advertising inventory to local establishments within Atmosphere’s vast network of small business venues.
  • As Small Business Saturday approaches on November 25, Atmosphere’s initiative stands as a testament to its commitment in giving back to its network of small businesses.
  • “At Atmosphere, small business is our business.
  • We activate screens in these small business venues as a platform for premium content and strategic marketing opportunities.

Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights

Retrieved on: 
Wednesday, November 8, 2023
Data Management, Other Health, Technology, Pharmaceutical, Oncology, General Health, Hospitals, Artificial Intelligence, Clinical Trials, Science, Biotechnology, Software, Other Science, Health, Research, NSCLC, GBM, DHL, Mantle cell lymphoma, Artificial intelligence, BBB, Lung, Rituximab, IO, USD, AI, Starlight, Lung cancer, Liver, Permeability, Antibody, Cancer, Machine learning, Pancreatic cancer, Brain, NHL, Safety, Therapy, Liquid biopsy, Patient, D, Central nervous system, DNA, Automation, ATM, Johns Hopkins School of Medicine, PD-1, Spacecraft, Fox Chase Cancer Center, MCL, Society, Education, Incidence, Patent, Bone marrow, Harmonic, CNS, Drug development, PDX, Algorithm, Breast, Glioblastoma, Metadata, Pharmaceutical industry, Medical device, Medical imaging, Nursing, Cryptocurrency, Lantern

Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning (“ML”) platform with multiple clinical-stage drug programs, today announced operational highlights and financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning (“ML”) platform with multiple clinical-stage drug programs, today announced operational highlights and financial results for the third quarter ended September 30, 2023.
  • Lantern plans to release additional details and data on this set of results with LP-284 in this setting in the coming month.
  • G&A Expenses: General and administrative expenses were approximately $1.3 million for the quarter ended September 30, 2023, compared to approximately $1.4 million for the quarter ended September 30, 2022.
  • Earnings Call and Webinar Details:
    Lantern will host its third quarter 2023 earnings call and webinar today, November 8, 2023, at 4:30 p.m.

NP Digital Celebrates Multiple Earned and Paid Media Award Wins at US Search Awards and Search Engine Land Awards

Retrieved on: 
Wednesday, November 1, 2023
Digital, NPD, Research, Adobe, Omnichannel, Content, Universal Technical Institute, SEO, SoFi, Partnership, Digital marketing, ConnectWise Control, Marketing, PPC, SAN, Lantern

The agency won Best Use of Search in Finance SEO for Lantern by SoFi and Best Use of Data in PPC for ConnectWise from the US Search Awards.

Key Points: 
  • The agency won Best Use of Search in Finance SEO for Lantern by SoFi and Best Use of Data in PPC for ConnectWise from the US Search Awards.
  • It won Best Enterprise SEO Campaign for Adobe from Search Engine Land Awards.
  • The agency's expertise and strategic approach won awards in both paid and earned media.
  • The agency used its paid media and data expertise to implement an omni-channel paid media campaign for the software company, ConnectWise.